Built with biopharmaceutical industry insights, this conference will bring together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.

With 20+ pioneering large pharma, biotech and academic experts who are shaping the landscape of mRNA- based therapeutics for the scientific community world-wide, hear how they address the major challenges facing the industry.

Key Highlights:

• Optimise the Efficacy, Cell- & Tissue- Specificity & Translatability of Your mRNA- Based Pipeline

 With the limitless opportunity of mRNA- based Therapeutics across different modalities, consider the challenges of efficacy and improve cell- & tissue- specificity with expert insights from Professor Drew Weissman, Strand Therapeutics & Chalmers University of Technology 

• Explore Applications of mRNA- Based Therapeutics Beyond Infectious Diseases

 From immune-oncology to rare and autoimmune diseases, dive into emerging applications and potential challenges of mRNA- based vaccines and therapeutics beyond infectious diseases with case studies from Moderna, BioNTech & Ethris 

• Navigate New & Emerging Delivery Technologies for mRNA- Based Therapeutics

 Take yourself to the forefront of mRNA delivery system development, from structure through to administration with insights from BioNTech, Johnson & Johnson & 20Med Therapeutics 

• Strategise Your Scalable & Global mRNA-Based Vaccine Development

 With the global outreach of mRNA- based vaccines, scalability is a major hurdle. Hear the latest technological advances and regulatory standards in mRNA- based vaccine and therapeutic landscape from Sanofi, Ziphius Vaccines & Arcturus Therapeutics 

• Tune into How Companies are Differentiating Their Pipelines Beyond mRNA- Based Vaccines

 With the success of mRNA- based vaccines fulfilling novel technologies and therapies such as mRNA- based protein replacement, hear from companies like Strand Therapeutics, Turn Biotechnologies & Orna Therapeutics on the emerging strategies that will enable innovation in the field

To know more visit: https://ter.li/og1teo